Clinical Trials Logo

Gynecologic Disease clinical trials

View clinical trials related to Gynecologic Disease.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT05897385 Recruiting - Postoperative Pain Clinical Trials

Analgesic Effect of IntraPeritoneal LIGNOcaine in Gynaecological Open Surgery

Start date: August 22, 2023
Phase: N/A
Study type: Interventional

The incidence of postoperative pain is highly prevalent among surgical patients. Inadequate postoperative pain control can slow the recovery and it increases the risk of postoperative complications, namely lung collapse and chronic pain. Although morphine is the one of the gold standard analgesia option for postoperative pain, it comes with many unwanted adverse effects, such as severe nausea and vomiting, low blood pressure and dizziness. Thus, multimodal analgesia regime, including local anaesthetic (lignocaine) is strongly advocated for postoperative analgesia. The normal route of lignocaine is injected into vein for the properties of analgesia and anti-inflammatory. It exerts its effect via the systemic absorption of drugs to block the central neuronal pain transmission. In recent years, studies have demonstrated that instillation of lignocaine inside abdominal cavity can reduce internal organ pain by blocking free nerve ending inside abdomen with minimal systemic absorption of drug and lower complications of systemic toxicity of local anaesthesia as compared to the intravenous route of lignocaine. Several RCTs showed the beneficial effect of intraperitoneal lignocaine for the reduction of postoperative visceral pain after laparoscopic surgery. However, gynaecological open surgery (cystectomy, hysterectomy) involves greater degree of manipulation and trauma on the internal organs with greater visceral pain, resulting in longer duration of hospitalisation and delayed functional mobility recovery. It is believed that the intraperitoneal lignocaine reduces inflammatory response after surgery and exert analgesia effect by blocking the neural signal transmission at site of tissue injury. Therefore, it is important to conduct this study to examine the analgesic effect of intraperitoneal lignocaine in women undergoing gynaecological open surgery.

NCT ID: NCT05518812 Recruiting - Gynecologic Disease Clinical Trials

Carboprost (Hemabate) for Fibroid Resection

Start date: July 12, 2022
Phase: Early Phase 1
Study type: Interventional

The purpose of this research study is to determine if low-dose (i.e., a fraction of what is commonly used) carboprost (Hemabate) helps facilitate fibroid removal (myomectomy).

NCT ID: NCT05509244 Recruiting - Gynecologic Disease Clinical Trials

Efficacy of Acetaminophen-ibuprofen Combination on the Postoperative Pain After Laparoscopic Gynecology Surgery

Start date: September 9, 2022
Phase: N/A
Study type: Interventional

Acetaminophen and ibuprofen has been safely used for a long time and reduces postoperative pain and opioid dosages. Investigators are planning to compare the efficacy of 1) acetaminophen only and 2) acetaminophen and ibuprofen combination at postoperative pain after laparoscopic gynecologic surgery.

NCT ID: NCT05125692 Recruiting - Gynecologic Disease Clinical Trials

Vaginal Repair of Post Cesarean Istmocele

OWarda
Start date: September 4, 2021
Phase: N/A
Study type: Interventional

20 WOMEN WITH SYMPTOMATIC POSTCESAREAN ISTHMOCELE (NICHE) WILL BE RECRUITED EVALUATED AND SUBJECTED TO A VAGINAL REPAIR OF THE DEFECT, RESULTS WILL BE ANALYZED.

NCT ID: NCT04963751 Recruiting - Gynecologic Disease Clinical Trials

ERAS in Pediatric & Adolescent Gynecology Preoperative Counseling

Start date: September 8, 2022
Phase: N/A
Study type: Interventional

The Investigator propose a randomized trial that will assess whether participant involvement in pre-operative counseling for ERAS improves post-surgical pain scores. The Investigator will also assess participant compliance to ERAS-prescribed medications, and functionality (return to school). Each participant who is enrolled in the study will be assigned to 1) pre-operative counseling with participant's caregiver or 2) caregiver-only counseling.

NCT ID: NCT04708353 Recruiting - Gynecologic Disease Clinical Trials

Oral Pregabalin Premedication for Postoperative Pain Relief

Start date: August 20, 2020
Phase: N/A
Study type: Interventional

Pain management after gynecological surgeries is essential for early mobilization of the patient, decrease postoperative complication and hospital stay. The use of opioids is associated with adverse effects such as nausea, vomiting, ileus, pruritus, sedation and respiratory depression. Previous studies stated that pregabalin has been used to reduce pre-operative anxiety, acute postoperative pain, postoperative opioid requirements, postoperative nausea, vomiting and postoperative delirium. The most effective dose of pregabalin to relief postoperative pain with least side effect is still under trial. In this study we will compare between two different doses of pregabalin when given as oral premedication in patients undergoing gynecological surgeries under spinal anesthesia regarding postoperative pain in order to reduce opioids consumption and subsequently avoid opioid-related adverse effects.

NCT ID: NCT04700761 Recruiting - Gynecologic Disease Clinical Trials

Opioid-free Anesthesia in Gynecologic Surgery

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

Post-operative nausea and vomiting (PONV) is common for the patients undergoing laparoscopic gynecologic surgery. PONV is a major factor for patient dissatisfaction, delayed patient recovery and increased medical expenses. Opioid-reducing anesthetic regimen is known to decrease PONV and facilitate early recovery after surgery (ERAS) and has been widely accepted recently. In this study, the researchers intend to investigate whether opioid-free anesthesia effectively reduces PONV, and whether it is clinically safe and feasible.

NCT ID: NCT03988348 Recruiting - Gynecologic Disease Clinical Trials

Perioperative Outcome of Infraumbilical Versus a Modified Intraumbilical Direct Trocar Insertion

Start date: August 4, 2019
Phase: N/A
Study type: Interventional

Laparoscopic surgery is now a well-established alternative to open surgery for many gynecological disorders owing to its faster wound healing, shorter hospital stay, less postoperative pain, and better cosmetic results. Postoperative scar cosmoses is a critical issue for women, especially for young women. These scars may have negative impacts, such as psychological consequences. The symptoms associated with the wound, such as pain, tenderness, and itching, can be induced by the scars

NCT ID: NCT03427840 Recruiting - Pain, Postoperative Clinical Trials

Superior Hypogastric Plexus Blockade in Laparoscopic Hysterectomy

Start date: March 18, 2018
Phase:
Study type: Observational

The primary indication for superior hypogastric plexus (SHP) block is visceral pelvic pain, most commonly from malignancy of the ovary, uterus, cervix, bladder, rectum or prostate. Per-cutaneous SHP blocks should be done under guidance of ultrasonography, fluoroscopy, magnetic resonance or computed tomography. During minimally invasive laparoscopic surgery, percutaneous technique can be done under the guidance of cameras.

NCT ID: NCT03395821 Recruiting - Gynecologic Disease Clinical Trials

Traditional Versus Virtual Reality for Surgical Skills for ObGyn Residents

SIMUTEC
Start date: December 22, 2017
Phase: N/A
Study type: Interventional

This study will verify if a comprehensive laparoscopic curriculum using virtual reality demonstrates skills transfer to the operating room, compared to the traditional teaching method.